Henry Ford + MSU researchers collaborate to shift pancreatic cancer outlook from bleak to bright
Pancreatic cancer is one of the most aggressive and deadly forms of cancer. The five-year survival rate is just 13%. On average, patients survive for only nine months after diagnosis and roughly 66,000 people are diagnosed in the U.S. each year. Now, researchers from Henry Ford Health and MSU are coming together to share their knowledge and expertise with the aim of changing this somber prognosis.
“I completely believe in team science,” said Jennifer Klomp, a pancreatic cancer researcher at Michigan State University. “I think the resulting science is better and more rigorous. You come at something with different approaches, different ways of thinking and different ideas. And the output, in the end, is more beneficial.”
National Medal of Science awarded to oncofertility innovator, MSU Research Foundation Professor Teresa Woodruff
Teresa K. Woodruff joined an elite group of Americans who have received two national medals of honor when President Joe Biden announced the latest recipients of the National Medal of Science on Jan. 3.
Arati Prabhakar, director of the White House Office of Science and Technology Policy, presented Woodruff with the medal at a ceremony at the Eisenhower Executive Office Building in Washington, D.C., on the same date.
MSU researchers use virtual reality to modernize health care training
Michigan State University researchers have developed a virtual reality curriculum to prepare health care professionals and students for the complexities of caring for patients with tracheostomies and laryngectomies.
Michigan State University researchers have developed a virtual reality curriculum to prepare health care professionals and students for the complexities of caring for patients with tracheostomies and laryngectomies.
Henry Ford Health, MSU announce 2024 cancer research award recipients
Henry Ford Health + Michigan State University Health Sciences has named the award recipients of the 2024 Cancer Seed Funding Program. Building on the success of the 2022 and 2023 cancer research pilot and integration award funding initiatives, this year the program awarded 14 new cancer research awards totaling $700,000.
“We are committed to supporting collaborative research to create a national and international destination for access to the most advanced cancer therapies and interventions,” said Ben Movsas, Henry Ford + MSU Cancer Committee co-chair, Henry Ford Cancer medical director and radiation oncology chair. “Our Henry Ford + MSU cancer researchers are demonstrating the power of coming together, with examples of previous recipients moving forward with federally funded research proposals.”